Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes

OBJECTIVE: Serum concentrations of the hepatokine fibroblast growth factor (FGF) 21 are elevated in obesity, type-2 diabetes, and the metabolic syndrome. We asked whether FGF21 levels differ between subjects with metabolically healthy vs. unhealthy obesity (MHO vs. MUHO), opening the possibility tha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Metab
Main Authors: Berti, Lucia, Irmler, Martin, Zdichavsky, Marty, Meile, Tobias, Böhm, Anja, Stefan, Norbert, Fritsche, Andreas, Beckers, Johannes, Königsrainer, Alfred, Häring, Hans-Ulrich, de Angelis, Martin Hrabě, Staiger, Harald
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4481465/
https://ncbi.nlm.nih.gov/pubmed/26137439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2015.04.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados